A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection

NCT07489482 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: SHR-3167 Injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.